Michael Seungju Yu portrait
  • Adjunct Professor, Molecular Pharmaceutics
  • Professor, Biomedical Engineering
  • Associate Professor, Biomedical Engineering


  • B.S., Chemistry, Korea University (Seoul, Korea)
  • Ph.D., Polymer Sci. & Eng., University of Massachusetts, Amherst

Research Summary

Dr. Yu is developing innovative diagnostic/therapeutic molecules, biomaterials, and piezoelectric materials. In particular, the collagen hybridizing peptide he developed and commercialized (3helix, Inc) is considered a breakthrough technology in detecting and studying collagen remodeling, with world-wide use in over a hundred different research labs. The technology is being developed into histology reagents, in vivo imaging probes, therapeutics, and cosmetics ingredients.